Second Opinion September 23, 2025
Christina Farr & Annalisa Merelli

As startups chase hot markets like GLP-1s and testosterone, the Trump Administration continues to push on wellness – and not always with the evidence to back it up. Deals are finally ramping up (and why). Plus a “Four Questions with” interview with digital health OG Halle Tecco!

Deals, deals, and more deals. After a long, quiet stretch on the fundraising front, I’m seeing a lot more companies getting funded, and even pre-empted. AI continues to be extremely hot and investors are moving to lead rounds earlier and earlier just to get in at valuations they can afford. With all this activity, very few people are stopping to discuss important questions, such as the steps that we need to take...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Govt Agencies, Mergers & Acquisitions / JV, Provider, Regulations, Technology, Trends, Wellness
Freeman Health System acquires Missouri facility to expand outpatient services
5 payer M&A deals | 2026
Healthcare & Life Sciences Private Equity Deal Tracker: Water Street Acquires Pillr From Renovus
Mirum Pharmaceuticals Completes $268.6 Million Acquisition of Bluejay Therapeutics to Strengthen Rare Disease Pipeline
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

Share Article